Importantly, these guidelines do not apply to men with symptoms of prostate cancer.
“There is general agreement that early detection, including prostate-specific antigen screening, has played a part in decreasing mortality from prostate cancer,” Dr. H. Ballentine Carter, chairman of the American Urological Assn. panel that developed the guideline, said in a statement. However, he added, “it’s time to reflect on how we screen men for prostate cancer and take a more selective approach in order to maximize benefit and minimize harms.”
You can read the full guideline online here.
Return to Science Now.